In the early 2000s, the board of what was then called the American Society for Therapeutic Radiology and Oncology (ASTRO) knew it needed a stronger voice in Washington, D.C., and broader offerings for its members.The organization was two-dimensional, focused on its annual meeting and flagship publication, the International Journal of Radiation Oncology.ASTRO hired Laura Thevenot as CEO in 2002, primarily for her advocacy expertise, and never looked back. Thevenot retired Nov. 1. During her tenure, she grew membership 50% and more than doubled the annual revenue to $24 million (as reported in its latest available tax disclosure). Thevenot significantly expanded staff (from… Read More